Major pharmaceutical firms' 2003 R&D strategies outlined
17 major pharmaceutical firms (excluding Dong-A, Choong-wae, Daewoong and Korea Green Cross) plans to concentrate their R&D efforts on the development of new antineoplastic agents using more advanced biotechnology techniques such as genomics and proteomics and expand their R&D investments...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
